Registry on assessing the quality of life improvement with triamcinolone in the treatment of moderate-to-severe persistent allergic rhinitis in egyptian patients-Reference-Cited by-同舟云学术

Registry on assessing the quality of life improvement with triamcinolone in the treatment of moderate-to-severe persistent allergic rhinitis in egyptian patients

Published:2016-10 Issue:4 Volume:32 Page:243-247
ISSN:1012-5574
Container-title:The Egyptian Journal of Otolaryngology
language:en
Short-container-title:Egypt J Otolaryngol

Author:

Elsammaa Mahmoud

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.4103/1012-5574.192547.pdf

Reference33 articles.

1. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (Suppl 5):S147–S334. Allergy 2008: 63 (Suppl 86): 8–160 Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LENFNx01and AllerGenFNx08)

2. Small P, Frenkiel S, Becker A, Boisvert P, Bouchard JMD, Carr S et al. The Canadian Rhinitis Working Group. Rhinitis: a practical and comprehensive approach to assessment and therapy. J Otolaryngol 2007;36 (Suppl 1):S5–S27.

3. Gawchik SM, Saccar CL. A risk-benefit assessment of intranasal triamcinolone acetonide in allergic rhinitis. Drug Saf 2000; 23: 309–322.

4. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008; 122(Suppl):S1–S84.

5. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomized controlled trials. BMJ 1998; 317: 1624–1629.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triamcinolone Acetonide in the Treatment of Perennial Allergic Rhinitis: A post hoc Analysis of Quality of Life during a Phase III Study;International Archives of Allergy and Immunology;2021-09-06